ETON - Eton Pharmaceuticals, Inc.

QQQ $ 455.25 $ 2.72 (0.6 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 1.93 (0.35 %)

TLT $ 99.96 $ 0.58 (0.58 %)

GLD $ 231.58 $ 0.32 (0.14 %)

Previous Close

$ 4.67

Open

$ 4.61

Bid

$ 4.67 x 191

Ask

-- x --

Day's Range

$ 4.61 - $ 4.80

52 Week Range

$ 3.03 - $ 5.81

Volume

312,326

Average Volume

Market Cap

120.66M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-14-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-16-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-16-2022	12-31-2021	10-K
12	11-16-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-16-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-05-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	03-25-2019	12-31-2018	10-K
24	12-20-2018	09-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Assumes Eton Pharmaceu...
09/04/2024 10:55:44

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Eton Pharmaceuticals (NASDAQ:ETON) with a Buy rating and anno...

Eton Pharmaceuticals Q2 2024 GAAP EPS $(0....
08/08/2024 21:12:40

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate o...

Eton Pharmaceuticals Received FDA Acceptan...
07/15/2024 20:07:38

- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 - - Product has patent protection through 2043 -

Eton Pharmaceuticals Q1 2024 GAAP EPS $(0....
05/09/2024 21:05:42

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of ...

Craig-Hallum Initiates Coverage On Eton Ph...
05/06/2024 16:40:30

Craig-Hallum analyst Chase Knickerbocker initiates coverage on Eton Pharmaceuticals (NASDAQ:ETON) with a Buy rating and anno...

Eton Pharmaceuticals Announces Submission ...
04/30/2024 11:01:44

Eton Pharmaceuticals, Inc ("Eton" or the "Company") (NASDAQ:ETON), an innovative pharmaceutical company focused...

Eton Pharmaceuticals Entered Agreements To...
04/18/2024 20:29:39

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/22/2024 13:06:12

Eton Pharmaceuticals Acquires Exclusive U....
03/22/2024 06:29:57

PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and s...

Recap: Eton Pharmaceuticals Q4 Earnings
03/14/2024 20:20:11

Eton Pharmaceuticals Q4 2023 GAAP EPS $(0....
03/14/2024 20:17:20

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate o...

Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Eton Pharmaceuticals Earnings Preview
03/13/2024 17:02:03

Eton Pharmaceuticals Won US Patent for Pro...
02/21/2024 11:55:02

Eton Pharmaceuticals ("Eton" or the "Company") (NASDAQ:ETON), an innovative pharmaceutical company focused on d...

Eton Pharmaceuticals Announces Commercial ...
02/02/2024 11:53:34

HC Wainwright & Co. Reiterates Buy on Eton...
12/11/2023 11:43:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $1...

Eton Pharmaceuticals: Q3 Earnings Insights
11/09/2023 21:36:04

Eton Pharmaceuticals Q3 EPS $(0.02) Beats ...
11/09/2023 21:30:32

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

Eton Pharmaceuticals Announces Acquisition...
10/04/2023 10:52:55

The acquired product was approved by the U.S. Food and Drug Administration (FDA) in May of 2023 for the treatment of hereditary...